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ABSTRACT
Background: The incidence of genital herpes simplex virus (HSV) has increased in recent years,
particularly among women of reproductive age. This places more neonates at risk for severe mor-
bidity and mortality. Treatment recommendations for primary disease in pregnancy are lacking,
particularly for those who acquire HSV remote from term.
Case: A patient at 17 weeks of gestation carrying dichorionic twins developed primary herpes
with subsequent vertical transmission of the virus and significant neonatal morbidity.
Conclusion: Data regarding risks and benefits of treatments such as acyclovir and immunopro-
phylaxis are lacking at a time when the incidence ofHSV infection is on the rise. Infect. Dis. Obstet.
Gynecol. 5:380-385, 1997. (C) 1998 Wiley-Liss, Inc.
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recent demographic study of the seropreva-
lence of type 2 herpes simplex virus (HSV-2)
antibody in the United States, conducted between
1988 and 1994, generated the following data:
women are significantly more likely to be seropos-
itive than men; during the study period, women in
their teens were more likely to be seropositive for
HSV-2 than during a prior study conducted be-
tween 1976 and 1980; and women of ethnic minor-
ity were more frequently seropositive than their
white counterparts. As the prevalence of HSV-2
infection among all women of reproductive age has
risen significantly, recent efforts have focused on
identification of risk factors for neonatal infection.
One such study of a large population of women
focused on HSV-2 acquisition during pregnancy,
and their findings suggested that antiviral chemo-
therapy may not be necessary if seroconversion oc-
curs prior to the third trimester, z The following
case report demonstrates that, occasionally, primary
HSV-2 infection prior to the third trimester may
result in a devastating outcome for the neonate.
CASE REPORT
The patient was a 26-year-old woman, gravida 3,
para 0, with an estimated gestational age of 31.5
weeks at the time of referral to our service for ul-
trasonographic evaluation of a dichorionic twin ges-
tation. She had had a primary outbreak of genital
herpes at 17.5 weeks. At that time, she reported
experiencing fever, malaise, and increased vaginal
discharge. Her oral temperature was 99.0F. Her
initial pelvic exam revealed no cervical lesions, but
there were a significant number of white blood
cells noted on the wet-mount culture (vaginal fluid
analysis) obtained at that time. There were also
several white blood cells noted on urinalysis. She
was treated for suspected urinary tract infection
with 500 mg of amoxicillin three times a day.
She returned two days later, and a repeat pelvic
exam revealed numerous ulcerations on her cervix
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consistent with herpes simplex infection. A culture
of these lesions tested positive for herpes. The cul-
tures were performed in the following manner:
specimens were vortexed in M5 transport media;
centrifugally inoculated onto MRC-5 cells in shell
vials; incubated at 35-37C; and inspected for cy-
topathic effect daily for five days. The presence of
herpes simplex virus (HSV) was confirmed in vials
that showed cytopathic effect by HSV-specific
fluorescent antibody. The patient was not treated
with antiviral chemotherapy at this time. Although
the patient’s history did not suggest risky behavior,
such as intravenous drug abuse or contact with
multiple sexual partners, the severity of her infec-
tion suggested increased risk for underlying immu-
nosuppression, either on the basis of pregnancy or
infection. Testing for human immunodeficiency
virus was offered to the patient, but she declined.
Her weight gain during pregnancy was appropriate,
and her absolute lymphocyte count was 1.5 thou-
sand/ml (normal range, 1.0-4.0 thousand/ml) at the
time of evaluation, suggesting lesser likelihood for
underlying human immunodeficiency virus infec-
tion.
The patient returned one week later reporting
significant spontaneous resolution of her symp-
toms. Serial speculum examinations of the cervix
were performed every one to two weeks following
initial presentation and revealed the persistence of
cervical lesions for a total of 52 days. There was
also one episode of labial infection during this pe-
riod. Three ultrasonographic examinations were
performed subsequent to the patient’s outbreak of
herpes, with the only significant finding being sus-
picion of lagging abdominal circumference in twin
A at 30 weeks of gestation, which prompted referral
to our service for further fetal evaluation.
Ultrasonographic examination at 31.5 weeks re-
vealed a dichorionic twin gestation. Twin B, a
1,503-g male, had enlargement of the cerebral atria
with drooping choroid plexus. This was not noted
on prior examination, but was seen to be present at
the 30-week examination upon review of the ultra-
sound films (Figures 1-4). The range of values ob-
tained for the diameter of the cerebral atria was
10.0-11.8 mm. The lateral ventricular width to
hemispheric width ratio and third and fourth ven-
tricles were all within normal limits. The cisterna
magna was mildly enlarged, with a measurement of
10.0 mm. Coronal imaging demonstrated normal
appearance of the corpus callosum. The remainder
of the anatomical survey was normal with the ex-
ception of the fetal spleen, with an anteroposterior
diameter of 13.5 mm and transverse diameter of
32.5 mm. Twin A, a 1,474-g female, was in a vertex
position that precluded examination of the fetal
cranium and contents by transabdominal ultrasono-
graphic imaging. The remainder of her anatomical
survey was within normal limits. After conferring
with the patient’s primary caretakers, we placed
the patient on a treatment regimen of 200 mg of
oral acyclovir five times per day for the remainder
of the pregnancy for suspected fetal herpes infec-
tion. The remainder of the pregnancy included
preterm labor, which was treated with bedrest and
oral tocolytic agents. Serial ultrasonographic exami-
nations of twin B demonstrated increasing cerebral
ventriculomegaly and progressive cerebellar hypo-
plasia (Figures 5, 6).
At 35.5 weeks, the patient began active labor
and quickly progressed to complete cervical dila-
tion. The patient’s perineum and distal vagina
were free of visible lesions when she arrived in
labor for delivery. Total duration of ruptured mem-
branes surrounding twin A prior to delivery was 4.5
hours. A fetal scalp electrode was placed at the
time of rupture of membranes. Vacuum-assisted
delivery of twin A was performed for fetal brady-
cardia, with delivery of an 1,853-g female with an
Apgar score of 9 at one minute and 9 at five min-
utes. Artificial rupture of membranes surrounding
twin B was then performed. Umbilical cord pro-
lapse with prolonged fetal bradycardia occurred,
and so primary lower uterine segment cesarean de-
livery was performed, with delivery of an 1,828-g
male infant with an Apgar score of 7 at one minute
and 8 at 5 minutes. The patient’s postoperative
recovery was uncomplicated.
Cranial ultrasonography of twin B shortly after
birth demonstrated marked dilation of the lateral
ventricles and fluid within the ambient cisterns
(Figure 7). Figure 8 demonstrates cranial findings
consistent with lissencephaly from computed to-
mography. Ophthalmologic examination obtained
on day three of the neonate’s life revealed severe
bilateral chorioretinitis. Initial eye, oral, and rectal
cultures for HSV were negative, and so intravenous
acyclovir was discontinued after consultation with
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Fig. I, 2, 3, 4. Figure demonstrates normal dimension of cerebral atria of male fetus at 22 weeks of gestation, 5 weeks after
diagnosis of maternal herpes infection. Figures 2, 3, and 4 illustrate the progression of abnormal enlargement of the cerebral
atria at 30, 32.5, and 34.5 weeks of gestation, respectively.
pediatric infectious disease specialists. Cerebral
spinal fluid was obtained from the male twin on the
first day of life, but there was not enough sample
available to process for viral culture. A gram stain of
cerebrospinal fluid was negative for organisms.
Toxoplasma IgM and urine cytomegalovirus were
negative. Evaluation of rapid plasma reagin was
nonreactive, and the mother was immune to ru-
bella. One month later, however, the male neonate
developed a fever and eye and skin lesions sugges-
tive of HSV. Cultures of cerebrospinal fluid and
the eye were obtained, and HSV was isolated.
Type HSV and type 2 IgG antibody titers were
positive at 3.26 and 3.21, respectively; Type HSV
and type 2 IgM antibody titers were negative at
0.72 and 0.23, respectively.
The female twin was also noted to have diffuse
low density in the cortex and subcortex consistent
with diffuse edema and encephalomalacia on cra-
nial computed tomography in the immediate neo-
natal period, but of lesser severity than her twin
(Figure 9). She demonstrated no chorioretinitis at
birth or on subsequent examinations. However, HSV
was demonstrated by use of polymerase chain reac-
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Fig. 7. Figure 7 represents the first cranial ultrasonogram
of the male neonate and shows dilation of the lateral ven-
tricles and fluid collections in the ambient cisterns. STANCE 43 6mm
+B CAL
Fig. 5, 6. Figure 5 is a measurement of the cisterna magna
of the male fetus at 32.5 weeks, which is at the upper limits
of normal for gestational age. Figure 6 demonstrates that at
34.5 weeks there was significant enlargement of the cisterna
magna and marked cerebellar atrophy.
tion testing of her cerebrospinal fluid obtained one
month after birth.
DISCUSSION
This case probably represents primary herpes in-
fection with vertical transmission in the second tri-
mester of pregnancy. Although serologic studies
Fig. 8. Cranial computed tomography demonstrating al-
most complete absence of gyri (lissencephaly) and calcifica-
tions in the basal ganglia, along with dilation of the ven-
tricles.
were not obtained at the time of the patient’s out-
break, established clinical criteria that suggest pri-
mary disease were present. These included the
presence of fever and malaise for more than 48
hours and the persistence of genital lesions for
greater than 16 days. The male fetus developed
progressive severe ventriculomegaly and cerebellar
hypoplasia during the late second and early third
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Fig. 9. Cranial computed tomography of the female neo-
nate on the first day of life. Although there were no frank
calcifications or ventriculomegaly noted, there is decreased
density seen throughout most of the cortex and subcortical
white matter, consistent with encephalomalacia or edema.
trimester after documentation of normal intracrani-
al anatomy at 21 weeks. This suggests acute sec-
ond-trimester insult. These findings in combina-
tion with neonatal chorioretinitis are virtually pa-
thognomonic for in utero herpes infection. It must
be acknowledged, however, that in the absence of
positive neonatal cultures, the pre- and postnatal
sonographic and computed tomography findings of
long-standing and severe disease could be attrib-
uted to another viral type. Likewise, one might
argue that the systemic herpes outbreak noted in
both twins one month after birth represents post-
natal acquisition of virus or horizontal spread be-
tween the neonates after twin A had rupture of
membranes and placement of fetal scalp electrode.
This may be the case for the female infant (twin
A), but the male infant was delivered by cesarean
within minutes of rupture of membranes, had no
fetal scalp electrode applied, and already demon-
strated evidence of long-standing in utero infec-
tion. Infectious etiology for the severe manifesta-
tions noted in the male infant also include chorio-
amnionitis in membranes that presumably lacked
contact with the internal os of the cervix and were
therefore less likely to acquire ascending infection
from the lower genital tract.
If this case does in fact represent vertical sec-
ond-trimester transmission, it is disturbing given
recent literature suggesting low risk for neonatal
morbidity with primary disease remote from term.
In perhaps the largest study to date of individuals
at risk for acquisition of herpes during pregnancy,
only 94 women had documented seroconversion, e
Furthermore, of the 34 symptomatic women, only
22 became infected during the first or second tri-
mester. In addition, some of these patients re-
ceived acyclovir. It was clear from this study that
patients with third-trimester seroconversion were
much more likely to manifest neonatal infection
than those infected earlier in pregnancy. It is more
difficult, however, to derive the risk for neonatal
infection on the basis of only 22 symptomatic pa-
tients with first- or second-trimester seroconver-
sion, some of whom may have received acyclovir.
The present case is consistent with a recent case
study that suggests that the placenta and/or mem-
branes may be easily traversed by the HSV family
of viruses, leaving little evidence for placental in-
fection on histologic examination.4
In terms of the obstetric management of this
case, several questions may be posed: 1) Why
wasn’t acyclovir prescribed at the time of initial
diagnosis of herpes infection? 2) Were HSV cul-
tures obtained near the time of delivery? 3) Why
was cesarean delivery not performed at the onset of
labor? and 4) Why was a fetal scalp electrode used
with known history of herpes cervicitis?
No randomized clinical trials exist from which to
generate recommendations for administration of
acyclovir for prevention of vertical transmission. In-
deed, it may be tempting to suggest that early and
aggressive treatment of the primary maternal her-
pes would obviate the fetal consequences. This is-
sue is controversial, however, as some authors have
suggested that the there may be a delay in the
humoral response to HSV after acyclovir therapy,s
Serial surveillance with weekly cervical cultures for
herpes virus has been abandoned due to ineffec-
tiveness in preventing neonatal infection. This
policy was adopted by the Infectious Disease So-
ciety for Obstetrics and Gynecology, who supports
the statement that "in the absence of documented
lesions or prodrome, vaginal delivery may be at-
tempted regardless of a history of genital herpes. ’’s
Examination of the patient in labor should include
visualization of the external genitalia, vagina, and
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cervix, and cesarean delivery should be offered
when prodrome or visible lesions arc present.
There is firm evidence to suggest that the use of
fetal scalp electrodes should be avoided in patients
with recent seroconversion to an HSV positive
state.6 Even this issue is debated, however, with
some authors advocating this form of intrapartum
fetal monitoring in the absence of genital lesions,s
In summary, this case probably represents sec-
ond-trimester vertical transmission of herpes sim-
plex virus with devastating outcomes for the neo-
nates. The number of patients with documented
primary outbreak of HSV in the second trimester is
quite small, and there are currently no large ran-
domized trials of acyclovir in pregnancy to decrease
the risk of vertical transmission during the first two
trimesters. Therefore, treatment recommendations
are lacking. We would suggest that there, is a large
registry in existence that does give patients and
their physicians the option to treat primary out-
breaks of HSV in pregnancy in order to attempt to
reduce risk of vertical transmission. 7 Without ran-
domized clinical trials, however, the effectiveness
and risks of this treatment in prevention of fetal
and neonatal disease will remain unknown.
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